skip to content

Clinical Trials

MainTitle

Advanced HIV Prevention (PrEP Chicago)

This study is currently recruiting participants. (see Contacts and Locations)

Verified January 2017 by University of Chicago

Sponsor
University of Chicago


Information provided by (Responsible Party)
University of Chicago
ClinicalTrials.gov Identifier
NCT02896699

First received: July 26, 2016
Last updated: January 26, 2017
Last Verified: January 2017
History of Changes
Purpose

Purpose

This study will evaluate the feasibility of a network intervention to train individuals to disseminate PrEP information and motivate initial PrEP interest and knowledge of PrEP in their social networks.

Condition Intervention
HIV

Behavioral : PrEP Intervention Group
Other : Control Group

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Advanced HIV Prevention (PrEP Chicago)

Further study details as provided by University of Chicago:

Primary Outcome Measures

  • Network member call into the PrEPline [ Time Frame: 2 years ]
Secondary Outcome Measures:
  • PrEP Attitudes questionnaire [ Time Frame: 2 years ]
    Monitor the change in attitude towards PrEP (1) from baseline measure to 12-months; (2) 12-months to 24-months; and (3) baseline to 24-month.
  • Peer change agent boosters sessions completed [ Time Frame: 2 years ]
  • Number of Facebook posts with respect to PrEP and sexual health [ Time Frame: 2 years ]
  • Number of referrals enrolled into the study [ Time Frame: 2 years ]

Estimated Enrollment: 240
Study Start Date: March 2016
Estimated Study Completion Date: December 2019
Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)

Arms Assigned Interventions
Experimental: PrEP Intervention Group
Group training session including HIV Education, PrEP Education, Following the training session Booster phone calls HIv and syphillis testing
Behavioral: PrEP Intervention Group
Active Comparator: Control Group
Group HIV risk vignettes
Other: Control Group

Detailed Description:

The specific aims of this study are:

  1. To recruit 240 participants in Chicago, Illinois, and to train them as peer change agents (randomized to cross-over groups) to disseminate PrEP information and motivate PrEP interest and knowledge of PrEP in their local networks.
  2. To evaluate feasibility of the program over 2 years of participant follow-up through: 1)
peer change agent exit survey; 2) peer change agent booster sessions; 3) peer change agent communication with University of Chicago PrEP program social media; 4) referrals into the project and; 5) calls into the PrEP warmline.

Eligibility

Eligibility

Ages Eligible for Study: 18 Years to 39 Years  
Sexes Eligible for Study: Male  
Accepts Healthy Volunteers: Yes  

Criteria

Inclusion Criteria:

  • Lives on the South Side of Chicago, Illinois
  • Born male
  • Has had sex with men in the previous year
  • Is an active Facebook user
  • Does not have plans to leave Chicago

Exclusion Criteria:

contacts and locations

Contacts and Locations

Choosing to participate in a study is an important personal decision.Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02896699

Contacts

Contact:   John Schneider 773-702-8349 jschnei1@medicine.bsd.uchicago.edu

Locations

United States, Illinois
University of Chicago Medical Center Recruiting
Chicago, Illinois, United States, 60637
Contact: John Schneider, MD    773-702-8349    jschnei1@medicine.bsd.uchicago.edu
Principal Investigator: John Schnedier, MD

Sponsors and Collaborators

University of Chicago
More Information

More Information


Responsible Party: University of Chicago  
ClinicalTrials.gov Identifier: NCT02896699   History of Changes  
Other Study ID Numbers: IRB15-1250  
Study First Received: July 26, 2016  
Last Updated: January 26, 2017  
Individual Participant Data    
Plan to Share IPD: No  

Keywords provided by University of Chicago:

Pre-exposure prophylaxis (PrEP)
diffusion of innovation
men who have sex with men
LGBT
African American
Black
HIV
network analysis
network intervention

ClinicalTrials.gov processed this data on October 20, 2017
This information is provided by ClinicalTrials.gov.